Search - tctmd.com

Displaying 201 - 220 of 260

Sort: Relevancy | Date

Presentation TCT 2015

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

Presenter: Mark C. Bates, Mark H. Wholey, Piotr Musialek

October 13, 2015

Presentation TCT 2015

TCT 71: Safety and Efficacy of Carotid Stenting With Proximal Embolic Protection Through Transradial/Brachial Approach Results in 60 Consecutive Patients

Presenter: Mark C. Bates, Mark H. Wholey, Piero Montorsi

October 13, 2015

Presentation TCT 2015

Chasing Migrating/Potentially Embolic Large RA Thrombi

Presenter: Praveer Agarwal, Praveen Chandra, Ajay J. Kirtane, Sreenivas Arramraju Kumar, Brian V Pinto, Pratap C. Rath, Shireesh P Sathe, Narenda N. Khanna

October 11, 2015

Presentation TCT 2015

Embolic Protection in Lower-Extremity Intervention: Where Does It Make the Most Sense?

Presenter: Hans Krankenberg, Lindsay S. Machan, Venkatesh Ramaiah

October 11, 2015

Presentation TCT 2015

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Robert T. Pyo, Bonnie H. Weiner, Davide Capodanno

October 11, 2015

Presentation Fellows 2015

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Manish A. Parikh, Tamim Nazif

May 16, 2015

Presentation

Proximal vs Distal Embolic Protection for CAS

Presenter: Jay Giri

April 24, 2015

Presentation

3-Year Outcomes Associated With Embolic Protection in Saphenous Vein Graft Intervention

Presenter: JM Brennan

March 27, 2015

Presentation

Mesh-Covered Embolic Protection Stent Implantation in STEMI

Presenter: Dariusz Dudek

February 18, 2015

Presentation TCT 2014

Outcomes with an Embolic Protection Stent in STEMI

Presenter: Francisco Fdez-Aviles, Abhiram Prasad, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Presenter: Marius Hornung

September 16, 2014

Presentation TCT 2014

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Presenter: Ferdinando Varbella

September 16, 2014

Presentation TCT 2014

The Emboline Aortic Embolic Protection Technology

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Scott Russell

September 15, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig, Davide Capodanno

September 12, 2014

Presentation

Evaluation of Proximal Protection Devices During CAS as the First Choice for Embolic Protection

Presenter: M. Hornung

July 28, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Advertisement

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

TCT 71: Safety and Efficacy of Carotid Stenting With Proximal Embolic Protection Through Transradial/Brachial Approach Results in 60 Consecutive Patients

Chasing Migrating/Potentially Embolic Large RA Thrombi

Embolic Protection in Lower-Extremity Intervention: Where Does It Make the Most Sense?

Atherotomy, Atherectomy, and Embolic Protection

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Proximal vs Distal Embolic Protection for CAS

3-Year Outcomes Associated With Embolic Protection in Saphenous Vein Graft Intervention

Mesh-Covered Embolic Protection Stent Implantation in STEMI

Outcomes with an Embolic Protection Stent in STEMI

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

The Emboline Aortic Embolic Protection Technology

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Atherotomy, Atherectomy, and Embolic Protection

Evaluation of Proximal Protection Devices During CAS as the First Choice for Embolic Protection

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content